Medical economics

Groups make own drugs to fight high drug prices, shortages

Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages ...

Medical economics

Patients burdened by cost of diagnostic imaging interpretations

(HealthDay)—Secondary interpretations of diagnostic imaging examinations result in small but real patient financial burdens, according to a study published online July 19 in the Journal of the American College of Radiology.

Vaccination

WHO urges COVID vaccine makers to keep prices down

The World Health Organization on Wednesday urged COVID-19 vaccine manufacturers to keep their prices low and affordable, after reports that two producers will raise the cost they are charging the EU.

Vaccination

Thailand to join COVAX, acknowledging low vaccine supply

The head of Thailand's National Vaccine Institute apologized Wednesday for the country's slow and inadequate rollout of coronavirus vaccines, promising it will join the U.N.-backed COVAX program to receive supplies from its ...

Medications

Dutch watchdog fines Italian drug company for surcharge

Italian pharmaceutical Leadiant has been fined almost 20 million euros for allegedly overcharging for medicine used to treat a rare cholesterol disease, the Dutch consumer watchdog said on Monday.

Other

UK regulator fines pharma firms for manipulating market

Britain's competition regulator announced Thursday it has imposed hundreds of millions of pounds in fines on several pharmaceutical firms for breaching the law in the supply of hydrocortisone tablets.

page 15 from 40